Matches in Nanopublications for { <http://rdf.disgenet.org/nanopublications.trig#NP316572.RAyphu2m_DrE4Kg8rG_K454n-JVpyhPTfwfHiqJqYEYQU130_assertion> ?p ?o ?g. }
Showing items 1 to 6 of
6
with 100 items per page.
- NP316572.RAyphu2m_DrE4Kg8rG_K454n-JVpyhPTfwfHiqJqYEYQU130_assertion type Assertion NP316572.RAyphu2m_DrE4Kg8rG_K454n-JVpyhPTfwfHiqJqYEYQU130_head.
- NP316572.RAyphu2m_DrE4Kg8rG_K454n-JVpyhPTfwfHiqJqYEYQU130_assertion description "[Variation within angiogenesis was most strongly associated with survival time overall (P = 0.03) and among patients with serous cancer (P = 0.05), particularly for EIF2B5 rs4912474 (all patients HR, 0.69; 95% CI, 0.54-0.89; P = 0.004), VEGFC rs17697305 (serous subtype HR, 2.29; 95% CI, 1.34-3.92; P = 0.003), and four SNPs in VHL.]. Sentence from MEDLINE/PubMed, a database of the U.S. National Library of Medicine." NP316572.RAyphu2m_DrE4Kg8rG_K454n-JVpyhPTfwfHiqJqYEYQU130_provenance.
- NP316572.RAyphu2m_DrE4Kg8rG_K454n-JVpyhPTfwfHiqJqYEYQU130_assertion evidence source_evidence_literature NP316572.RAyphu2m_DrE4Kg8rG_K454n-JVpyhPTfwfHiqJqYEYQU130_provenance.
- NP316572.RAyphu2m_DrE4Kg8rG_K454n-JVpyhPTfwfHiqJqYEYQU130_assertion SIO_000772 20103664 NP316572.RAyphu2m_DrE4Kg8rG_K454n-JVpyhPTfwfHiqJqYEYQU130_provenance.
- NP316572.RAyphu2m_DrE4Kg8rG_K454n-JVpyhPTfwfHiqJqYEYQU130_assertion wasDerivedFrom befree-20140225 NP316572.RAyphu2m_DrE4Kg8rG_K454n-JVpyhPTfwfHiqJqYEYQU130_provenance.
- NP316572.RAyphu2m_DrE4Kg8rG_K454n-JVpyhPTfwfHiqJqYEYQU130_assertion wasGeneratedBy ECO_0000203 NP316572.RAyphu2m_DrE4Kg8rG_K454n-JVpyhPTfwfHiqJqYEYQU130_provenance.